Group 1 - The company currently has a total nuclear power order backlog of approximately 2.9 billion yuan [1] - Within the group, the nuclear power order backlog is about 1.6 billion yuan, with new orders signed this year amounting to around 600 million yuan [1]

Group 1: Financial Performance and Orders - The company has a total of approximately ¥2.9 billion in hand nuclear power orders, with ¥1.6 billion from the group and about ¥600 million in new orders signed this year [4]. - The expected gross margin for nuclear power valves is closely related to the product output structure, with variations based on pricing ability, cost composition, and market competition [3]. - The company aims to maintain a steady performance in 2025, with a focus on optimizing business structure and enhancing core competitiveness [12]. Group 2: Production Capacity and Expansion - The company’s nuclear power production capacity can currently support the production of valves for 8 reactor units, with plans to increase this to 10 units after the completion of the third phase of construction by mid-2026 [6]. - The first two phases of capacity expansion have been completed, enhancing testing, processing, and storage capabilities [6]. - The company is actively pursuing capacity expansion in the nuclear sector to meet strategic development opportunities [14]. Group 3: Technological Development and Market Strategy - The company is focusing on high-end valve localization strategies and aims to support the development of fusion reactor valve equipment [7]. - It has a comprehensive product range in both nuclear and non-nuclear fields, with strong research and product integration capabilities [14]. - The company is committed to continuous technological innovation and digital transformation to enhance core competitiveness and expand market share [11]. Group 4: Industry Engagement and Project Involvement - The company has been actively involved in coal chemical projects since 2014, achieving significant milestones in valve development for coal chemical processes [9]. - Recent bids for projects include upgrades for coal-to-oil facilities and hydrogenation units, with successful order acquisitions [10]. - The company has a history of significant orders in the coal chemical sector, collaborating with major clients in the industry [10].

Core Viewpoint - The company, China Nuclear Technology (000777.SZ), is currently experiencing good overall capacity utilization and is focusing on expanding its production capacity in several key areas to meet upcoming strategic opportunities in the nuclear power sector [1] Group 1: Capacity Expansion Focus - The company aims to accelerate capacity expansion and automation in the nuclear sector to address challenges related to capacity matching during the strategic development phase of nuclear power [1] - In the oil and petrochemical sector, the company is focusing on intelligent upgrades and equipment renewal as a core strategy [1] - In the energy and utilities sector, the company plans to implement phased construction of facilities and equipment investment to actively develop conventional and new product capacities [1]

Core Viewpoint - The performance of the Zhongzheng 2000 ETF Enhanced (159556) has shown a decline of 2.20% as of the midday close on September 2, with a trading volume of 2.0863 million yuan [1] Group 1: Fund Performance - The Zhongzheng 2000 ETF Enhanced (159556) has a performance benchmark based on the Zhongzheng 2000 Index return [1] - Since its establishment on December 27, 2023, the fund has achieved a return of 18.85% [1] - The fund's return over the past month is reported at 9.45% [1] Group 2: Major Holdings - Major stocks in the fund include: - Zhenhua New Materials, down 1.72% - Hengbao Co., down 8.57% - Yongding Co., down 6.21% - Yong'an Pharmaceutical, down 2.03% - Xuguang Electronics, down 1.07% - Zhongke Technology, down 1.89% - Juguang Technology, down 3.61% - Huitong Energy, down 2.42% - Xinke Materials, down 2.41% - Batian Co., down 3.71% [1]

Core Viewpoint - Zhongke Technology (000777) reported a moderate performance in its 2025 interim financial results, with total revenue increasing by 9.43% year-on-year, but showing a decline in quarterly revenue and net profit in Q2 2025 compared to Q2 2024 [1] Financial Performance - Total revenue for the first half of 2025 reached 704 million yuan, up 9.43% from 2024's 643 million yuan [1] - Net profit attributable to shareholders was 76.83 million yuan, a 1.68% increase from 75.56 million yuan in 2024 [1] - In Q2 2025, total revenue was 466 million yuan, down 4.49% year-on-year, and net profit was 75.02 million yuan, down 2.69% [1] - Gross margin decreased to 19.55%, down 19.97% year-on-year, while net margin fell to 10.91%, down 7.09% [1] - Total operating expenses were 92.95 million yuan, accounting for 13.2% of revenue, a decrease of 15.2% year-on-year [1] Balance Sheet and Cash Flow - Cash and cash equivalents increased by 48.14% to 188 million yuan [1] - Accounts receivable rose by 13.15% to 1.281 billion yuan, representing 558.65% of net profit [1][2] - Interest-bearing debt decreased by 8.59% to 283 million yuan [1] - Operating cash flow per share was -0.8 yuan, a decrease of 2.37% year-on-year [1] Investment Metrics - Return on Invested Capital (ROIC) for the previous year was 10.5%, indicating average capital returns [1] - Historical median ROIC over the past decade was 7.51%, with a notably low ROIC of 2.91% in 2017 [1] Fund Holdings - The largest fund holding Zhongke Technology is the Golden Eagle Technology Innovation Stock A, with 4.97 million shares, newly entering the top ten holdings [3] - The fund has a total scale of 3.19 billion yuan and a recent net value increase of 2.5% [3] Corporate Actions - The company has been actively engaged in due diligence and discussions regarding a major asset restructuring, which was ultimately terminated [4] - The company adhered to regulatory requirements and maintained confidentiality during the process [4]

Group 1 - The stock price of China Nuclear Technology as of August 27, 2025, is 20.86 yuan, down 0.69 yuan or 3.20% from the previous trading day [1] - The opening price for the day was 21.51 yuan, with a high of 21.69 yuan and a low of 20.85 yuan, and the trading volume reached 198,560 hands with a transaction amount of 424 million yuan [1] - The main business of China Nuclear Technology includes the design, manufacturing, and sales of industrial valves, which are widely used in nuclear power, oil, and chemical industries [1] Group 2 - According to the latest financial report, China Nuclear Technology's net profit attributable to shareholders for the first half of 2025 is 76.8274 million yuan, representing a year-on-year increase of 1.68% [1] - On August 27, the net outflow of main funds was 66.0393 million yuan, with a cumulative net outflow of 92.3443 million yuan over the past five days [1]

中核苏阀科技实业股份有限公司 关于中核财务有限责任公司 2025 年半年度风险评估报告 根据《深圳证券交易所上市公司自律监管指引第7号——交易与 关联交易》的要求，中核苏阀科技实业股份有限公司（以下简称"本 公司"）通过查验中核财务有限责任公司（以下简称 "中核财务"） 《金融许可证》、《营业执照》等证件资料，并审阅中核财务公司出具 的包括资产负债表、损益表、现金流量表等在内的定期财务报告，对 中核财务公司的经营资质、业务和风险状况进行了评估，具体情况报 告如下： 一、中核财务公司基本情况 中核财务隶属中国核工业集团有限公司，是由中国核工业集团有 限公司及其部分成员单位共同出资设立的非银行金融机构，经中国人 民银行批复（银复〔1997〕249 号文），中核财务目前持有国家金融 监督管理总局北京监管局于2023年8月23日颁发的机构编码为 L0011H211000001的金融许可证。中核财务目前持有北京市市场监督 管 理 局 于 2025 年 3 月 17 日 颁 发 的 统 一 社 会 信 用 代 码 为 91110000100027235R 的营业执照。 注册地址：北京市海淀区玲珑路9号院东区10号楼7至8 ...

中核苏阀科技实业股份有限公司 2025 年半年度财务报告 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 1 中核苏阀科技实业股份有限公司 2025 年半年度财务报告 | 流动资产合计 | 2,410,341,345.66 | 2,454,049,618.78 | | --- | --- | --- | | 非流动资产： | | | | 发放贷款和垫款 | | | | 债权投资 | | | | 其他债权投资 | | | | 长期应收款 | | | | 长期股权投资 | 682,373,676.87 | 634,942,882.06 | | 其他权益工具投资 | 344,575,749.44 | 225,120,304.07 | | 其他非流动金融资产 | | | | 投资性房地产 | | | | 固定资产 | 205,985,665.44 | 212,068,925.89 | | 在建工程 | 19,172,614.35 | 18,565,218.00 | | 生产性生物资产 | | | | ...

关于中核苏阀科技实业股份有限公司 2025 半年度 非经营性资金占用及其关联资金往来的专项说明 2025 半年度非经营性资金占用及其他关联资金往来情况汇总表 上市公司名称：中核苏阀科技实业股份有限公司 单位：万元 | 非经营性资 | 资金占用方 | 占用方与上 | 上市公司核 | 2025 年期初 | 2025 年半年 度占用累计 | 2025 年半年 度占用资金 | 2025 年半年 | 2025 年半年 | 往来形成原 | 往来性质（经 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 金占用 | 名称 | 市公司的关 | 算的会计科 | 往来资金余 | 发生金额（不 | 的利息（如 | 度偿还累计 | 度期末占用 | 因 | 营性往来、非 | | | | 联关系 | 目 | 额 | 含利息） | 有） | 发生金额 | 资金余额 | | 经营性往来） | | 控股股东、实 | | | | | | | | | | | | 际控制人及 | | | | | | | | | | | | 其附属企业 | | | | | ...

证券代码：000777 证券简称：中核科技 公告编号：2025-058 中核苏阀科技实业股份有限公司 关于举办2025年半年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 中核苏阀科技实业股份有限公司（以下简称"公司"）已于 2025 年 8 月 28 日在巨潮资 讯网披露了《2025 年半年度报告》《2025 年半年度报告摘要》。为便于广大投资者更加全 面深入地了解公司经营业绩、发展战略等情况，公司计划于 2025 年 9 月 5 日（星期五） 14:00-15:00 举办中核苏阀科技实业股份有限公司 2025 年半年度业绩说明会。 一、说明会召开的时间、地点和方式 会议召开时间：2025 年 9 月 5 日（星期五）14:00-15:00 会议召开方式：现场＋网络文字互动 网络会议地点：价值在线（www.ir-online.cn） 现场会议地点：苏州市虎丘区珠江路 501 号中核科技 108 会议室 证券代码：000777 证券简称：中核科技 公告编号：2025-058 二、参加人员 董事长 马瀛，董事、副总经理（主持工作） 龙云飞，独 ...